Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Brinton Pharmaceuticals gets DCGI’s approval to launch favipiravir anti-viral tablets in India

expresspharmaJuly 24, 2020

Tag: Brinton , DCGI , favipiravir , Faviton

PharmaSources Customer Service